The news appears is favorable. China. Bintai and Malaysia, and now New Zealand and Australia. There is nothing for Generex to do but keep executing. Eventually, something will trigger the stock. Test results, receipt of monies, signing another prospect (Singapore, South Africa, Canada, southeast Asia). Investors should stick to their guns. If all these things come to pass, stock will do 10x and more. Stay the course.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links